Champions Oncology holds annual stockholder meeting
CSBR•Champions Oncology shareholders approved the 2026 Equity Incentive Plan and ratified EisnerAmper LLP as auditor for the fiscal year ending April 30, 2027. All seven director nominees were elected at the October 14, 2026, meeting.
1. Meeting results
Shareholders approved the 2026 Equity Incentive Plan, ratified EisnerAmper LLP as independent auditor for the fiscal year ending April 30, 2027, and elected all seven director nominees at the annual meeting on October 14, 2026.
